By expenditures
| Name | Title | Type |
|---|---|---|
| Jordan Wade | Vice President for Business & CFO | Auditee |
| Ellen Zarfas | Associate Vice President for Finance / Controller | Auditee |
| Patricia Shelton | VICE PRESIDENT FOR BUSINESS & CFO | Auditee |
| Christopher Gordon, Cpa | Partner | Auditee |
| Tammara Williamson, Cpa | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 344190 | 2024 | 2025-02-27 | Capincrouse LLP | $5.78M |
| 294999 | 2023 | 2024-03-13 | Capincrouse LLP | $6.77M |
| 28940 | 2022 | 2023-02-09 | Capincrouse LLP | $10.13M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 344190 | 2024 | 2025-02-27 | 1101254 | 2024-003 | - | Yes | L |
| 344190 | 2024 | 2025-02-27 | 1101253 | 2024-003 | - | Yes | L |
| 344190 | 2024 | 2025-02-27 | 1101252 | 2024-002 | - | - | L |
| 344190 | 2024 | 2025-02-27 | 1101251 | 2024-001 | Significant Deficiency | Yes | N |
| 344190 | 2024 | 2025-02-27 | 1101250 | 2024-001 | Significant Deficiency | Yes | N |
| 344190 | 2024 | 2025-02-27 | 524812 | 2024-003 | - | Yes | L |
| 344190 | 2024 | 2025-02-27 | 524811 | 2024-003 | - | Yes | L |
| 344190 | 2024 | 2025-02-27 | 524810 | 2024-002 | - | - | L |
| 344190 | 2024 | 2025-02-27 | 524809 | 2024-001 | Significant Deficiency | Yes | N |
| 344190 | 2024 | 2025-02-27 | 524808 | 2024-001 | Significant Deficiency | Yes | N |
| 294999 | 2023 | 2024-03-13 | 952389 | 2023-003 | - | - | L |
| 294999 | 2023 | 2024-03-13 | 952388 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 952387 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 952386 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 952385 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 952384 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 952383 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 952382 | 2023-001 | Material Weakness | - | N |
| 294999 | 2023 | 2024-03-13 | 952381 | 2023-001 | Material Weakness | - | N |
| 294999 | 2023 | 2024-03-13 | 375947 | 2023-003 | - | - | L |
| 294999 | 2023 | 2024-03-13 | 375946 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 375945 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 375944 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 375943 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 375942 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 375941 | 2023-002 | Significant Deficiency | - | N |
| 294999 | 2023 | 2024-03-13 | 375940 | 2023-001 | Material Weakness | - | N |
| 294999 | 2023 | 2024-03-13 | 375939 | 2023-001 | Material Weakness | - | N |
| 28940 | 2022 | 2023-02-09 | 610265 | 2022-003 | - | - | L |
| 28940 | 2022 | 2023-02-09 | 610264 | 2022-003 | - | - | L |
| 28940 | 2022 | 2023-02-09 | 610263 | 2022-002 | - | Yes | N |
| 28940 | 2022 | 2023-02-09 | 610262 | 2022-002 | - | Yes | N |
| 28940 | 2022 | 2023-02-09 | 33823 | 2022-003 | - | - | L |
| 28940 | 2022 | 2023-02-09 | 33822 | 2022-003 | - | - | L |
| 28940 | 2022 | 2023-02-09 | 33821 | 2022-002 | - | Yes | N |
| 28940 | 2022 | 2023-02-09 | 33820 | 2022-002 | - | Yes | N |